Hansa Biopharma: Interview with CEO Søren Tulstrup (video)

Research Interview

2022-02-07

07:00

Redeye interviewed Søren Tulstrup, CEO of Hansa Biopharma, in conjunction with the company's Q4 report. Amongst the topics discussed are commercial opportunities, the launch of Idefirix in Europe, and the company's pipeline.

JU

Johan Unnerus

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.